Marc Schegerin - Sqz Biotechnologies Independent Director
Insider
Marc Schegerin is Independent Director of Sqz Biotechnologies Co since 2020.
| Tenure | 5 years |
| Phone | 617 758 8672 |
| Web | https://www.sqzbiotech.com |
Marc Schegerin Latest Insider Activity
Tracking and analyzing the buying and selling activities of Marc Schegerin against Sqz Biotechnologies stock is an integral part of due diligence when investing in Sqz Biotechnologies. Marc Schegerin insider activity provides valuable insight into whether Sqz Biotechnologies is net buyers or sellers over its current business cycle. Note, Sqz Biotechnologies insiders must abide by specific rules, including filing SEC forms every time they buy or sell Sqz Biotechnologies'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Marc Schegerin over a year ago Acquisition by Marc Schegerin of 875 shares of Sqz BiotechnologiesC subject to Rule 16b-3 |
Sqz Biotechnologies Management Efficiency
The company has Return on Asset of (0.3332) % which means that on every $100 spent on assets, it lost $0.3332. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (1.0493) %, meaning that it generated no profit with money invested by stockholders. Sqz Biotechnologies' management efficiency ratios could be used to measure how well Sqz Biotechnologies manages its routine affairs as well as how well it operates its assets and liabilities.Sqz Biotechnologies Co has 27.47 M in debt with debt to equity (D/E) ratio of 0.74, which is OK given its current industry classification. Sqz Biotechnologies has a current ratio of 3.79, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for Sqz to invest in growth at high rates of return.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Leila MD | Pmv Pharmaceuticals | 61 | |
| Stacy Markel | Nuvation Bio | 60 | |
| Gary Hattersley | Nuvation Bio | 58 | |
| Chulani Karunatilake | Werewolf Therapeutics | 65 | |
| Christine MBA | SAB Biotherapeutics | 69 | |
| Roger Rush | Inhibikase Therapeutics | N/A | |
| Robert Bazemore | Nuvation Bio | 53 | |
| Timothy CPA | Werewolf Therapeutics | 67 | |
| Oleg Nodelman | Nuvation Bio | 44 | |
| Sanjay Chanda | AN2 Therapeutics | 60 | |
| Paul MD | AN2 Therapeutics | 54 | |
| Daniel Welch | Nuvation Bio | 63 | |
| Eddie Sullivan | SAB Biotherapeutics | 59 | |
| Deborah Knobelman | Senti Biosciences | 50 | |
| Reid Leonard | Werewolf Therapeutics | 65 | |
| MBA BS | AN2 Therapeutics | 49 | |
| Michael Alley | AN2 Therapeutics | N/A | |
| David Hanley | Nuvation Bio | 55 | |
| LLM JD | Candel Therapeutics | 64 | |
| Edward MD | Third Harmonic Bio | 52 | |
| Anne McKay | Fennec Pharmaceuticals | 70 | |
Management Performance
| Return On Equity | -1.05 | |||
| Return On Asset | -0.33 |
Sqz Biotechnologies Leadership Team
Elected by the shareholders, the Sqz Biotechnologies' board of directors comprises two types of representatives: Sqz Biotechnologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sqz. The board's role is to monitor Sqz Biotechnologies' management team and ensure that shareholders' interests are well served. Sqz Biotechnologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sqz Biotechnologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Marshelle MD, Chief Officer | ||
| Teri Loxam, Chief Financial Officer | ||
| Howard Bernstein, Chief Scientific Officer | ||
| Marc Schegerin, Independent Director | ||
| Richard CPA, Chief Officer | ||
| Pushkal Garg, Independent Director | ||
| Oliver Rosen, Chief Medical Officer | ||
| Klavs Jensen, Independent Director | ||
| David First, Chief People Officer | ||
| Paul Bolno, Independent Director | ||
| Howard MD, Interim Director | ||
| Armon Sharei, President, Chief Executive Officer, Founder, Interim Chief Financial Officer, Director | ||
| Bernard Coulie, Independent Director | ||
| Amy Schulman, Chairman of the Board | ||
| Marc Elia, Independent Director | ||
| Micah Zajic, Chief Business Officer | ||
| Sapna Srivastava, Independent Director | ||
| Patrick Vink, Independent Director | ||
| Lawrence Knopf, General Counsel | ||
| Ipsita Roymoulik, VP QUALITY |
Sqz Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sqz Biotechnologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.05 | |||
| Return On Asset | -0.33 | |||
| Operating Margin | (3.92) % | |||
| Current Valuation | (6.5 M) | |||
| Shares Outstanding | 29.49 M | |||
| Shares Owned By Insiders | 3.12 % | |||
| Shares Owned By Institutions | 66.58 % | |||
| Number Of Shares Shorted | 811.15 K | |||
| Price To Book | 0.50 X | |||
| Price To Sales | 1.24 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Consideration for investing in Sqz Stock
If you are still planning to invest in Sqz Biotechnologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sqz Biotechnologies' history and understand the potential risks before investing.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |